The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.

Moderna’s COVID-19 vaccine has received full FDA approval for use in children at higher risk for severe illness.

July 14 (UPI) -- Health experts say in recent years the number of kids taken ill after ingesting nicotine products has surged ...

This is what it looks like when disinformation doctors pretend to value data and science to further their true objective, ...

Does colchicine work for CVD or doesn’t it? That’s the question the study authors hoped to answer, but there’s little ...

Traditionally, individuals asked health questions of their primary health care provider. Confidence in that provider as a ...

While we believe pricing pressure will persist across some of Hologic’s products, we forecast gross margins to hover around 59% through fiscal 2029 as the firm increases its recurring revenue of ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...

Collection of ethnicity data in clinical research has been poor historically, but is essential to ensure that interventions are effective and safe across diverse populations. These data are needed to ...

California Creates Housing Agency: After years of soaring rents, increasingly out-of-reach home prices and an enduring homelessness crisis that touches every corner of the state, California is finally ...

An 8-year-old boy, wheelchair-bound due to a rare genetic disease, HPDL deficiency, regained his mobility through an ...